Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (181-190 of 755) with videos related to

Pageof 76
Sort By:
The Journal of Rheumatology|March 1, 1993
New classification of antirheumatic drugs. The evolution of a conceptJ P Edmonds, D L Scott, D E Furst, et al.
Contemporary Clinical Trials|September 16, 2010
Handling missing data issues in clinical trials for rheumatic diseasesWeng Kee Wong, W J Boscardin, A E Postlethwaite, et al.
The Journal of Rheumatology|August 13, 2009
Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosisLeona A Holmberg, Daniel E Furst, Peter A McSweeney, et al.
Statistical Methods in Medical Research|March 7, 2007
Assessing disease progression using a composite endpointWeng Kee Wong, Daniel E Furst, Philip J Clements, et al.
Arthritis Research & Therapy|September 15, 2007
Clinical trials in systemic sclerosis: lessons learned and outcomesMarco Matucci-Cerinic, Virginia D Steen, Daniel E Furst, et al.
Lupus|January 12, 2018
Secular trends in the impact factors of SLE publications over a 45-year period-a systematic reviewN Cohen, M Mimouni, M M Glatstein, et al.
International Journal of Rheumatology|December 12, 2017
Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDsWilliam F C Rigby, Kathy Lampl, Jason M Low, et al.
Water Research|July 18, 2018
Tradeoffs between pathogen inactivation and disinfection byproduct formation during sequential chlorine and chloramine disinfection for wastewater reuseKirin E Furst, Brian M Pecson, Brie D Webber, et al.
Journal of Clinical Pharmacology|July 1, 1983
Clinical pharmacology of tolmetin: comparisons in rheumatoid arthritis patients and normal volunteersD E Furst, S H Dromgoole, R K Desiraju, et al.
The Journal of Rheumatology|December 1, 2004
High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forwardDaniel E Furst, Richard Nash, Keith M Sullivan, et al.
Pageof 76

Showing results (181-190 of 755) with videos related to

Sort By:
Pageof 76
The Journal of Rheumatology|March 1, 1993
New classification of antirheumatic drugs. The evolution of a conceptJ P Edmonds, D L Scott, D E Furst, et al.
Contemporary Clinical Trials|September 16, 2010
Handling missing data issues in clinical trials for rheumatic diseasesWeng Kee Wong, W J Boscardin, A E Postlethwaite, et al.
The Journal of Rheumatology|August 13, 2009
Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosisLeona A Holmberg, Daniel E Furst, Peter A McSweeney, et al.
Statistical Methods in Medical Research|March 7, 2007
Assessing disease progression using a composite endpointWeng Kee Wong, Daniel E Furst, Philip J Clements, et al.
Arthritis Research & Therapy|September 15, 2007
Clinical trials in systemic sclerosis: lessons learned and outcomesMarco Matucci-Cerinic, Virginia D Steen, Daniel E Furst, et al.
Lupus|January 12, 2018
Secular trends in the impact factors of SLE publications over a 45-year period-a systematic reviewN Cohen, M Mimouni, M M Glatstein, et al.
International Journal of Rheumatology|December 12, 2017
Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDsWilliam F C Rigby, Kathy Lampl, Jason M Low, et al.
Water Research|July 18, 2018
Tradeoffs between pathogen inactivation and disinfection byproduct formation during sequential chlorine and chloramine disinfection for wastewater reuseKirin E Furst, Brian M Pecson, Brie D Webber, et al.
Journal of Clinical Pharmacology|July 1, 1983
Clinical pharmacology of tolmetin: comparisons in rheumatoid arthritis patients and normal volunteersD E Furst, S H Dromgoole, R K Desiraju, et al.
The Journal of Rheumatology|December 1, 2004
High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forwardDaniel E Furst, Richard Nash, Keith M Sullivan, et al.
Pageof 76